Linezolid Pharmacokinetics/Pharmacodynamics-Based Optimal Dosing for Multidrug-Resistant Tuberculosis-Reference-Cited by-同舟云学术

Linezolid Pharmacokinetics/Pharmacodynamics-Based Optimal Dosing for Multidrug-Resistant Tuberculosis

Published:2022-06 Issue:6 Volume:59 Page:106589
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Zhou Wenqiang,Nie Wenjuan,Wang Qingfeng,Shi Wenhui,Yang Yang,Li Qi,Zhu Hui,Liu Zhongquan,Ding Yangming,Lu Yu,Chu Naihui^ORCID

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference45 articles.

1. World Health Organization. Global tuberculosis report 2021. Geneva: World Health Organization; 2021. https://www.who.int/tb/publications/global_report/en [accessed 29 January 2022].

2. Linezolid for treatment of chronic extensively drug-resistant tuberculosis;Lee;N Engl J Med,2012

3. Linezolid for XDR-TB–Final Study Outcomes;Lee;N Engl J Med,2015

4. Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in China;Tang;Eur Respir J,2015

5. Fourteen-Day Bactericidal Activity, Safety, and Pharmacokinetics of Linezolid in Adults with Drug-Sensitive Pulmonary Tuberculosis;Diacon;Antimicrob Agents Chemother,2020

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population pharmacokinetics and dosage optimization of linezolid in Chinese older patients;European Journal of Clinical Pharmacology;2024-05-27

2. Treatment outcome, recurrence and safety of multidrug-resistant TB treated with low-dose linezolid;The International Journal of Tuberculosis and Lung Disease;2023-12-01

3. Rifampicin reduces plasma concentration of linezolid in patients with infective endocarditis;Journal of Antimicrobial Chemotherapy;2023-10-12

4. Pharmacokinetic analysis of linezolid for multidrug resistant tuberculosis at a tertiary care centre in Mumbai, India;Frontiers in Pharmacology;2023-01-04

5. Treatment options for children with multi-drug resistant tuberculosis;Expert Review of Clinical Pharmacology;2022-11-27